VSTM
Verastem Inc
NASDAQ: VSTM · HEALTHCARE · BIOTECHNOLOGY
$5.46
+1.11% today
Updated 2026-04-30
Market cap
$479.62M
P/E ratio
—
P/S ratio
15.51x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$4 – $11
Volume
2.0M
Verastem Inc (VSTM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-330000.00 | $-10.13M | $-22.60M | $-26.30M | $-36.90M | $-45.56M | $-29.48M | $-57.31M | $-74.52M | $-138.52M | $-33.51M | $-53.50M | $-63.67M | $-86.46M | $-104.77M | $-137.51M |
| Capital expenditures | $8000.00 | $785000.00 | $310000.00 | $56000.00 | $2.43M | $211000.00 | $39000.00 | $1.51M | $23.51M | $7000.00 | $33000.00 | $196000.00 | $0.00 | $7000.00 | $28000.00 | $9.62M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $1.64M | $7.40M | $9.68M | $12.36M | $10.09M | $6.29M | $5.03M | $6.67M | $8.54M | $8.12M | $7.71M | $6.05M | $5.86M | $7.34M | $9.40M |
| Free cash flow | $-338000.00 | $-10.92M | $-22.91M | $-26.36M | $-39.33M | $-45.77M | $-29.52M | $-58.82M | $-98.02M | $-138.53M | $-33.54M | $-53.70M | $-63.67M | $-86.47M | $-104.80M | $-147.13M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $15000.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-10.86M | $8.79M | $15.01M | $-9.03M | $7.48M | $49.83M | $48.27M | $-51.35M | $-11.24M | $-46.53M | $54.30M | — | — | — |